A new study shows that nine out of every 10 breast cancer patients in Nigeria and Ghana have to pay for their breast cancer diagnostic tests and treatment themselves.
In Kenya, the figure stands at three out of every 10 patient, says the report by Switzerland-based biotech company Roche.
Roche says these delays, coupled with the high cost of treatment, have contributed to high mortality rates across Sub Saharan Africa.
A patient’s chance of survival can be impacted by delays in diagnosis and treatment, limitations in access to appropriate and quality cancer care, and financial burdens associated with receiving care.
Patients also face significant delays and lengthy waiting times for diagnostic tests and treatment.
Waiting times for surgery stands at at least four months.
Breast cancer is the leading cause of cancer-related deaths in women in Nigeria, Ghana and Kenya.
Latest Stories
-
2024 All Africa Challenge Trophy: Morocco to host Women’s Golf event slated for November 28
2 hours -
Man City throw away 3-0 lead to draw with Feyenood
3 hours -
Ghanaians, your vote matters: Let us secure the future with Dr. Bawumia
4 hours -
Saka stars as Arsenal thrash Sporting
4 hours -
Black Queens friendlies against Senegal and Tunisia in limbo due to lack of $40k
4 hours -
Salah not distracted by contract talks – Slot
4 hours -
Lewandowski reaches 100 Champions League goals
4 hours -
Traders at Mallam Atta Market give Bawumia rousing reception
4 hours -
World’s oldest man dies aged 112
4 hours -
With God all things are possible – Bawumia to worshipers at Hebron Prayer Camp
4 hours -
Are 300,000 migrant children missing in the US?
4 hours -
Trump proves he is serious on tariffs – but it’s not about trade
4 hours -
Bawumia to commission electric buses on Wednesday
4 hours -
CSIR-SARI encourages farmers in Northern Ghana to embrace newly developed climate-smart, high-yielding Cowpea variety
4 hours -
Biden announces Israel and Hezbollah ceasefire deal agreed
4 hours